STAT
SEPTEMBER 18, 2023
In the wake of growing alarm over the disproportionately high rates of maternal mortality in the U.S., maternal health experts have been pushing for changes — including expanding the midwife workforce. Studies have shown that deliveries attended by midwives tend to have fewer complications and better outcomes, partially because midwife training relies less on medical intervention, leading to fewer C-sections.
PharmaVoice
SEPTEMBER 18, 2023
An effort to spare the species from blood collection is one of many ways the industry is turning away from animals for R&D.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
SEPTEMBER 18, 2023
David Liu, the Broad Institute biochemist behind two powerful forms of genome editing, is launching a company focused on delivering gene-editing machinery to precise cells and tissues in the body, STAT has learned. The company, known as Nvelop, already raised a $100 million seed round last year, according to PitchBook. It is being run by Jeff Walsh, a former top executive at Bluebird Bio, and it recently recruited Bluebird’s head of research, Melissa Bonner, according to two people with k
Pharma Times
SEPTEMBER 18, 2023
The updated vaccines more closely target current circulating variants - News - PharmaTimes
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
SEPTEMBER 18, 2023
Comments to antitrust regulators lay bare Americans’ anger and disillusionment over consolidation’s effects on all sectors of the economy, but especially health care. A 24-year-old wrote that after his hometown hospital in Indiana merged with a bigger group, his mom, who worked there, found it harder to provide good care amid staff cuts and reduced support.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
STAT
SEPTEMBER 18, 2023
The era of rampant, unconsented, and unregulated online data collection may finally be winding down for consumer health data. But the advances in consumer privacy have not yet fully reached the millions of people with health information related to their drug use, substance use disorder treatment, or recovery. In July, two key agencies for consumer health privacy, the Department of Health and Human Services and the Federal Trade Commission, sent letters to 130
PharmaVoice
SEPTEMBER 18, 2023
The visual inspection of injectable drug product has been a regulatory requirement since 1936, however, successful implementation of the standard has been challenging for many organizations.
STAT
SEPTEMBER 18, 2023
Medicare plans to pay more for a type of cardiac rehabilitation that takes place in certain outpatient clinics owned by hospitals. Medicare has admitted it is doing so due to an error in reading federal law, but it also goes against the grain of the current environment, where support for site-neutral payments has never been higher. Some members of Congress and health care experts are pushing for a system that would not pay hospital outpatient departments more for identical services that are prov
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
SEPTEMBER 18, 2023
Good morning, everyone, and welcome to another working week. We hope the weekend respite was restful and invigorating because now that familiar routine of meetings and deadlines and what-not has returned. As you might expect, we are coping by quaffing a few cups of welcome stimulation — our flavor today is southern pecan — and, as always, we invite you to join us.
World Pharma News
SEPTEMBER 18, 2023
Vividion Therapeutics, Inc. (Vividion), announced today that it has initiated dosing of patients in a Phase I oncology clinical trial of its investigational oral Kelch-like ECH Associated Protein 1 (KEAP1) activator, VVD-130037. Vividion is a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision therapeutics for devastating cancers and immune disorders, and a wholly owned and independently operated subsidiary of Ba
BioPharma Dive
SEPTEMBER 18, 2023
Three years after gaining European approval, Libmeldy is now under U.S. review with a deadline set for March.
Pharmaceutical Technology
SEPTEMBER 18, 2023
Embattled biotech giant Illumina has led series A funding into genomics mapping company Broken String Biosciences.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
pharmaphorum
SEPTEMBER 18, 2023
Allis.health – a digital health analyst in your pocket Phil.
Drug Patent Watch
SEPTEMBER 18, 2023
The article “Maximizing the Value of Drug Patents Before Losing Exclusivity” discusses strategies for biomedical companies to maximize the value of their drug patents before the exclusivity period expires. In… The post Maximizing Drug Patents’ Value: Strategies for Biomedical Companies appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
SEPTEMBER 18, 2023
US researchers start trials of universal flu vaccine Phil.
Express Pharma
SEPTEMBER 18, 2023
Biocon has approved the appointment of Peter Bains as the Group CEO, with effect from September 18, 2023. He will be reporting directly to Biocon Group Chairperson, Kiran Mazumdar-Shaw. Bains has accordingly stepped down from his role on the Biocon Board as an Independent Director with immediate effect, to assume this strategic executive responsibility.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
pharmaphorum
SEPTEMBER 18, 2023
CHMP backs Almirall’s eczema therapy lebrikizumab Phil.
The Pharmacist
SEPTEMBER 18, 2023
NICE has approved rimegepant as the first treatment for acute migraine, in draft guidance published this month. Around 13,000 could benefit from rimegepant (Vydura, Pfizer), said NICE after signing off its use in adults who have tried at least two triptans but they did not work well enough. It can also be used for those […] The post NICE to recommend rimegepant as first acute migraine treatment appeared first on The Pharmacist.
pharmaphorum
SEPTEMBER 18, 2023
Dutch R&D agency spins out health wearables company Phil.
Pharmaceutical Technology
SEPTEMBER 18, 2023
The FDA released a draft guidance giving advice on the correct labelling of biosimilar and interchangeable biosimilar products.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
pharmaphorum
SEPTEMBER 18, 2023
GSK gets wide FDA approval for myelofibrosis drug Phil.
BioPharma Dive
SEPTEMBER 18, 2023
With the rise of ChatGPT and artificial intelligence (AI), there are many ways the clinical staffing industry can use AI advantageously while removing the stigma that the rise of technology can be dehumanizing.
Outsourcing Pharma
SEPTEMBER 18, 2023
The French-U.S. company Novadiscovery has hailed a âwatershed moment for clinical trial designâ as its trial simulation tool successfully predicted the outcome of a phase 3 oncology trial run by AstraZeneca.
European Pharmaceutical Review
SEPTEMBER 18, 2023
The first and only treatment for anaemic patients with myelofibrosis has been approved by the US Food and Drug Administration (FDA). Ojjaara (momelotinib) is indicated for intermediate or high-risk myelofibrosis, a blood cancer, including primary myelofibrosis or secondary myelofibrosis (post-polycythaemia vera and post-essential thrombocythaemia), in adults with anaemia.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Technology
SEPTEMBER 18, 2023
Despite major shifts in the IBD landscape, most approaches that go beyond targeting inflammation remain in the earlier stages of development.
Outsourcing Pharma
SEPTEMBER 18, 2023
The small molecule drug Ojjaara (momelotinib), developed by GlaxoSmithKline, has become the first U.S. Food and Drug Administration (FDA)-approved treatment for patients with the blood cancer myelofibrosis and anemia.
The Pharmacist
SEPTEMBER 18, 2023
The patient group directions (PGDs) that will enable community pharmacists in England to provide a common conditions service are currently being worked through by government and NHS England (NHSE), Community Pharmacy England (CPE) chief executive Janet Morrison has confirmed. The service will utilise seven PGDs to allow community pharmacists to treat – including with antibiotics […] The post Pharmacy First PGDs ‘being worked through’ appeared first on The Pharmacist.
Expert insights. Personalized for you.
363 
Let's personalize your content